chimeric antigen receptor cell therapy

Dona Potter was treated with a new immunotherapy that entails re-engineering a patient’s T cells to target cancer.

Patient’s cancer treatment includes new immunotherapy

Dona Potter, 87, rode Harleys and drove 18-wheelers back when men dominated the open highways, and she is still defying expectations.